starting dose for retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide clinical trial dose People

However, individuals with a history of depression or mental health issues should be closely monitored while using these medications

Some patients using GLP-1 medications for weight management have reported hair thinning or alopecia, particularly with semaglutide (Wegovy) and tirzepatide (Zepbound)

Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonist

For help finding clinical nutrition care, call 310-825-7921

Connect with a menopause-expert physician at Alloy to review your symptoms, discuss your metabolic risks, and explore treatment options that support your health in menopause

This happened just in the next 3 years